Closing the access barrier for effective anti-malarials in the private sector in rural Uganda: consortium for ACT private sector subsidy (CAPSS) pilot study

BACKGROUND: Artemisinin-based combination therapy (ACT), the treatment of choice for uncomplicated falciparum malaria, is unaffordable and generally inaccessible in the private sector, the first port of call for most malaria treatment across rural Africa. Between August 2007 and May 2010, the Uganda...

Descripción completa

Detalles Bibliográficos
Autores principales: Talisuna, Ambrose O, Daumerie, Penny Grewal, Balyeku, Andrew, Egan, Timothy, Piot, Bram, Coghlan, Renia, Lugand, Maud, Bwire, Godfrey, Rwakimari, John Bosco, Ndyomugyenyi, Richard, Kato, Fred, Byangire, Maria, Kagwa, Paul, Sebisubi, Fred, Nahamya, David, Bonabana, Angela, Mpanga-Mukasa, Susan, Buyungo, Peter, Lukwago, Julius, Batte, Allan, Nakanwagi, Grace, Tibenderana, James, Nayer, Kinny, Reddy, Kishore, Dokwal, Nilesh, Rugumambaju, Sylvester, Kidde, Saul, Banerji, Jaya, Jagoe, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3523984/
https://www.ncbi.nlm.nih.gov/pubmed/23107021
http://dx.doi.org/10.1186/1475-2875-11-356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3523984/
https://www.ncbi.nlm.nih.gov/pubmed/23107021
http://dx.doi.org/10.1186/1475-2875-11-356

Ejemplares similares